Sundar PichaiSundar Pichai earned $164M in 2023

Christopher Garabedian has shown a strong financial commitment to Sarepta Therapeutics. His insider trading activity reflects significant stock holdings with values fluctuating dramatically. For instance, in December 2019, his holdings peaked at approximately $48.54 million. However, fluctuations occurred as values...

Recent Insider Trades

SRPT

$9.45K

SRPT at $11.82/share

Feb 27, 2015

Purchase

Rivals

Competitors/colleagues of Christopher Garabedian

Christopher Garabedian

Ex-CEO of Sarepta Therapeutics, Inc.

CG

View Compensation History

2016 Total Compensation

$979.00K

Salary

$550.00K

Bonus

$429.00K

Stock

$0.00

Other

$0.00